ZURA BIO LTD (ZURA) Stock Income Statement
NASDAQ:ZURA - Nasdaq - KYG9TY5A1016 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 0.00 | 0.00 | 200.00K | N/A | N/A | |||
| Operating Expenses | 66.00M | 55.00M | 63.00M | 2.68M | 890.00K | |||
| Research and Development | 31.28M | 24.40M | 44.00M | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 34.49M | 31.00M | 19.00M | 2.68M | 890.00K | |||
| Operating Income | -66.00M | -55.00M | -63.00M | -2.68M | -890.00K | |||
| Interest Income/Expense | 3.97M | 2.76M | 4.30M | 6.22M | 10.26M | |||
| Other Income/Expense | -10.00K | 30.00K | -2.23M | 0.00 | -2.52M | |||
| Income Before Taxes | -62.00M | -52.00M | -61.00M | 3.55M | 6.85M | |||
| Income Tax | N/A | 0.00 | 0.00 | N/A | N/A | |||
| Net Income | -62.05M | -45.00M | -69.00M | 3.55M | 6.85M | |||
| EBITDA | N/A | -54.99M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.72 | -0.60 | -2.09 | 0.21 | 0.40 | |||
| Non GAAP EPS | -0.72 | -0.55 | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD